138 research outputs found

    Why Sprawl is a Problem: Interview with Evan Richert

    Get PDF
    A recent report of the Maine State Planning Office entitled The Cost of Sprawl (May 1997) begins with the observation.... We are spreading out. Over the last 30 years, the fastest growing towns in Maine have been new suburbs 10 to 25 miles distant from metropolitan areas....These high growth communities have accounted for virtually all of the state\u27s population growth. From town square to the countryside, from Main Street to the mall, we are dispersing.... This outward movement has had unanticipated and unintended consequences.... Such consequences are the focus of this interview with Evan Richert, director of the Maine State Planning Office. Richert points out that sprawl has implications for Maine\u27s fiscal integrity, quality of environment, and character of communities. As policymakers continue to focus on reducing tax burden and promoting economic development, Richert points out that the issue of sprawl will need to be factored into our solutions. He calls for statewide dialogue and suggests pursuing economic incentives rather than a regulatory approach to curb this pattern of development. Richert also comments on the status of utility restructuring. He is joined by State Economist Laurie Lachance for this portion of the interview

    Scenario Planning for Building Coastal Resilience in the Face of Sea Level Rise: The Case of Jacobs Avenue, Eureka, CA

    Get PDF
    This article examines issues surrounding flood control measures for the Jacobs Avenue community located in Eureka, California. This area of northern California is experiencing some of the most rapid rates of sea level rise recorded throughout the state. Researchers conducted interviews with stakeholders, developed geospatial analyses, and reviewed policy documents in order to understand the social, environmental, and political context related to sea level rise planning for Jacobs Avenue. From this information we developed a scenario-based set of management options to guide stakeholders in future decision-making regarding the fate of Jacobs Avenue. We explored the potential challenges and benefits of three possible scenarios: no action, levee improvement, and strategic retreat. Our analysis reveals that there are no easy solutions. Lack of funding and lack of a clear political path towards retreat make it extremely difficult for planners to take proactive steps that might ultimately contribute to increased safety, as well as economic and environmental benefits, for flood-vulnerable communities. The scenario framework developed in this paper can be a useful tool for a wide range of coastal communities, in particular those of geographically isolated northern California and southern Oregon

    Scenario Planning for Building Coastal Resilience in the Face of Sea Level Rise: The Case of Jacobs Avenue, Eureka, CA

    Get PDF
    This article examines issues surrounding flood control measures for the Jacobs Avenue community located in Eureka, California. This area of northern California is experiencing some of the most rapid rates of sea level rise recorded throughout the state. Researchers conducted interviews with stakeholders, developed geospatial analyses, and reviewed policy documents in order to understand the social, environmental, and political context related to sea level rise planning for Jacobs Avenue. From this information we developed a scenario-based set of management options to guide stakeholders in future decision-making regarding the fate of Jacobs Avenue. We explored the potential challenges and benefits of three possible scenarios: no action, levee improvement, and strategic retreat. Our analysis reveals that there are no easy solutions. Lack of funding and lack of a clear political path towards retreat make it extremely difficult for planners to take proactive steps that might ultimately contribute to increased safety, as well as economic and environmental benefits, for flood-vulnerable communities. The scenario framework developed in this paper can be a useful tool for a wide range of coastal communities, in particular those of geographically isolated northern California and southern Oregon

    Piano Showcase Recital

    Get PDF

    Immune mediators in the tumor microenvironment of prostate cancer

    Full text link
    Prostate cancer tissue is composed of both cancer cells and host cells. The milieu of host components that compose the tumor is termed the tumor microenvironment (TME). Host cells can be those derived from the tissue in which the tumor originates (e.g., fibroblasts and endothelial cells) or those recruited, through chemotactic or other factors, to the tumor (e.g., circulating immune cells). Some immune cells are key players in the TME and represent a large proportion of non‐tumor cells found within the tumor. Immune cells can have both anti‐tumor and pro‐tumor activity. In addition, crosstalk between prostate cancer cells and immune cells affects immune cell functions. In this review, we focus on immune cells and cytokines that contribute to tumor progression. We discuss T‐regulatory and T helper 17 cells and macrophages as key modulators in prostate cancer progression. In addition, we discuss the roles of interleukin‐6 and receptor activator of nuclear factor kappa‐B ligand in modulating prostate cancer progression. This review highlights the concept that immune cells and cytokines offer a potentially promising target for prostate cancer therapy.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152631/1/cac2s4088001701983.pd

    Immune mediators in the tumor microenvironment of prostate cancer

    Full text link
    Prostate cancer tissue is composed of both cancer cells and host cells. The milieu of host components that compose the tumor is termed the tumor microenvironment (TME). Host cells can be those derived from the tissue in which the tumor originates (e.g., fibroblasts and endothelial cells) or those recruited, through chemotactic or other factors, to the tumor (e.g., circulating immune cells). Some immune cells are key players in the TME and represent a large proportion of non‐tumor cells found within the tumor. Immune cells can have both anti‐tumor and pro‐tumor activity. In addition, crosstalk between prostate cancer cells and immune cells affects immune cell functions. In this review, we focus on immune cells and cytokines that contribute to tumor progression. We discuss T‐regulatory and T helper 17 cells and macrophages as key modulators in prostate cancer progression. In addition, we discuss the roles of interleukin‐6 and receptor activator of nuclear factor kappa‐B ligand in modulating prostate cancer progression. This review highlights the concept that immune cells and cytokines offer a potentially promising target for prostate cancer therapy.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152631/1/cac2s4088001701983.pd

    LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin

    Get PDF
    SummaryThe LKB1 (also called STK11) tumor suppressor is mutationally inactivated in ∌20% of non-small cell lung cancers (NSCLC). LKB1 is the major upstream kinase activating the energy-sensing kinase AMPK, making LKB1-deficient cells unable to appropriately sense metabolic stress. We tested the therapeutic potential of metabolic drugs in NSCLC and identified phenformin, a mitochondrial inhibitor and analog of the diabetes therapeutic metformin, as selectively inducing apoptosis in LKB1-deficient NSCLC cells. Therapeutic trials in Kras-dependent mouse models of NSCLC revealed that tumors with Kras and Lkb1 mutations, but not those with Kras and p53 mutations, showed selective response to phenformin as a single agent, resulting in prolonged survival. This study suggests phenformin as a cancer metabolism-based therapeutic to selectively target LKB1-deficient tumors

    Immune mediators in the tumor microenvironment of prostate cancer

    Full text link
    Abstract Prostate cancer tissue is composed of both cancer cells and host cells. The milieu of host components that compose the tumor is termed the tumor microenvironment (TME). Host cells can be those derived from the tissue in which the tumor originates (e.g., fibroblasts and endothelial cells) or those recruited, through chemotactic or other factors, to the tumor (e.g., circulating immune cells). Some immune cells are key players in the TME and represent a large proportion of non-tumor cells found within the tumor. Immune cells can have both anti-tumor and pro-tumor activity. In addition, crosstalk between prostate cancer cells and immune cells affects immune cell functions. In this review, we focus on immune cells and cytokines that contribute to tumor progression. We discuss T-regulatory and T helper 17 cells and macrophages as key modulators in prostate cancer progression. In addition, we discuss the roles of interleukin-6 and receptor activator of nuclear factor kappa-B ligand in modulating prostate cancer progression. This review highlights the concept that immune cells and cytokines offer a potentially promising target for prostate cancer therapy.http://deepblue.lib.umich.edu/bitstream/2027.42/136176/1/40880_2017_Article_198.pd
    • 

    corecore